With Five-Year Ban On Fetal Tissue Studies Lifted, Scientists Are Striving To Make Up For Lost Time

With Five-Year Ban On Fetal Tissue Studies Lifted, Scientists Are Striving To Make Up For Lost Time Author: MYRNA E. WATANABE, pp.1 delayed by the moratorium, that may relieve human suffering Sometime this month, the National Institutes of Health will announce the recipients of the first federal grants since 1988 for research on human fetal tissue transplants using material derived from elective abortions--the main source of live and healthy fetal tissue that can be maintained in culture

Written byMyrna Watanabe
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Author: MYRNA E. WATANABE, pp.1

Sometime this month, the National Institutes of Health will announce the recipients of the first federal grants since 1988 for research on human fetal tissue transplants using material derived from elective abortions--the main source of live and healthy fetal tissue that can be maintained in culture and used for therapeutic transplants.

Proposals for the projects were submitted in early 1993, only a few days after newly inaugurated President Bill Clinton lifted a five-year- old moratorium on federal funding for such research. Throughout the ban's duration, it was vociferously challenged by scientists who regarded it as a serious roadblock in the pursuit of cures for many human diseases; the ire of these scientists was heightened by the widespread assumption that the moratorium resulted from pressure applied on the White House by anti- abortion groups.

The moratorium prevailed until this year, however, despite the recommendations by a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies